All Stories

  1. Long-term oncologic outcomes of papillary thyroid microcarcinoma according to the presence of clinically apparent lymph node metastasis: a large retrospective analysis of 5,348 patients
  2. Long-term Recurrence of Small Papillary Thyroid Cancer and Its Risk Factors in a Korean Multicenter Study
  3. Relationship of Focally Amplified Long Noncoding on Chromosome 1 (FAL1) lncRNA with E2F Transcription Factors in Thyroid Cancer
  4. GLI1 Transcription Factor Affects Tumor Aggressiveness in Patients With Papillary Thyroid Cancers
  5. Thyroid Dysfunction Associated With Follicular Cell Steatosis in Obese Male Mice and Humans
  6. Aberrant Expression of COT Is Related to Recurrence of Papillary Thyroid Cancer
  7. KSR1 is coordinately regulated with Notch signaling and oxidative phosphorylation in thyroid cancer
  8. A Metabolic Phenotype Based on Mitochondrial Ribosomal Protein Expression as a Predictor of Lymph Node Metastasis in Papillary Thyroid Carcinoma
  9. A SIRT7-Dependent Acetylation Switch of GABPβ1 Controls Mitochondrial Function
  10. Sirt1 induction confers resistance to etoposide-induced genotoxic apoptosis in thyroid cancers
  11. Pharmacological Inhibition of Poly(ADP-Ribose) Polymerases Improves Fitness and Mitochondrial Function in Skeletal Muscle
  12. Circadian Rhythm Disruption and Metabolic Syndrome
  13. Clinical implications of follicular and Hurthle cell carcinoma in an iodine-sufficient area
  14. Follicular and Hurthle cell carcinoma of the thyroid in iodine-sufficient area: retrospective analysis of Korean multicenter data
  15. IGF‐1 receptor deficiency in thyrocytes impairs thyroid hormone secretion and completely inhibits TSH‐stimulated goiter
  16. The NAD+/Sirtuin Pathway Modulates Longevity through Activation of Mitochondrial UPR and FOXO Signaling
  17. RAF kinase inhibitor-independent constitutive activation of Yes-associated protein 1 promotes tumor progression in thyroid cancer
  18. Crif1 Deficiency Reduces Adipose OXPHOS Capacity and Triggers Inflammation and Insulin Resistance in Mice
  19. Mitochondrial oxidative phosphorylation reserve is required for hormone- and PPARγ agonist-induced adipogenesis
  20. NAD(P)H: Quinone Oxidoreductase 1 and NRH:Quinone Oxidoreductase 2 Polymorphisms in Papillary Thyroid Microcarcinoma: Correlation with Phenotype
  21. Prediction of Occult Central Lymph Node Metastasis in Papillary Thyroid Carcinoma by PreoperativeBRAFAnalysis Using Fine-Needle Aspiration Biopsy: A Prospective Study
  22. CRIF1 Is Essential for the Synthesis and Insertion of Oxidative Phosphorylation Polypeptides in the Mammalian Mitochondrial Membrane
  23. Dual specificity phosphatase 6 as a predictor of invasiveness in papillary thyroid cancer
  24. Aberrant L1 Cell Adhesion Molecule Affects Tumor Behavior and Chemosensitivity in Anaplastic Thyroid Carcinoma
  25. L1 cell adhesion molecule as a novel independent poor prognostic factor in gallbladder carcinoma
  26. Pyrosequencing cut‐off value identifying BRAF V600E mutation in fine needle aspiration samples of thyroid nodules
  27. Downregulation of erythropoietin receptor by overexpression of phospholipase C-gamma 1 is critical for decrease on focal adhesion in transformed cells
  28. Cross-Regulation between Oncogenic BRAFV600E Kinase and the MST1 Pathway in Papillary Thyroid Carcinoma
  29. Mitochondrial Localization and Regulation of BRAFV600E in Thyroid Cancer: A Clinically Used RAF Inhibitor Is Unable to Block the Mitochondrial Activities of BRAFV600E
  30. Antidiabetic and Antiobesity Effects of Ampkinone ( 6f ), a Novel Small Molecule Activator of AMP-Activated Protein Kinase
  31. Genetic Analyses of the Chimeric CYP11B1 / CYP11B2 Gene in a Korean Family with Glucocorticoid-Remediable Aldosteronism
  32. L1 Cell Adhesion Molecule Is a Novel Independent Poor Prognostic Factor of Extrahepatic Cholangiocarcinoma
  33. Pharmacological Stimulation of NADH Oxidation Ameliorates Obesity and Related Phenotypes in Mice
  34. Expression of miRNA 146a/b, 221 and 222 in Thyroid Cancer
  35. Identification of Growth Regulatory Factors in Medullary Thyroid Carcinoma Cell Line
  36. Diagnostic value of pyrosequencing for the BRAFV600Emutation in ultrasound-guided fine-needle aspiration biopsy samples of thyroid incidentalomas
  37. Clinical Characteristics of Primary Thyroid Lymphoma in Koreans
  38. Change in Thyroid Autoantibodies According to the Clinical Course of Painless Thyroiditis Excluding Postpartum Thyroiditis
  39. A Case of Multiple Endocrine Neoplasia Type I with Atypical Clinical Course
  40. Body Mass Index is Associated with USF1 Haplotype in Korean Premenopausal Women
  41. The Effects of D-Chiro-Inositol on Glucose Metabolism in 3T3-L1 Cells
  42. Regulation of Inhibitors of Differentiation Family Proteins by Thyroid-Stimulating Hormone in FRTL-5 Thyroid Cells
  43. Tumor Suppressor LKB1 Inhibits Activation of Signal Transducer and Activator of Transcription 3 (STAT3) by Thyroid Oncogenic Tyrosine Kinase Rearranged in Transformation (RET)/Papillary Thyroid Carcinoma (PTC)
  44. Predictive Value of the Preablation Serum Thyroglobulin Level After Thyroidectomy Is Combined With Postablation 131I Whole Body Scintigraphy for Successful Ablation in Patients With Differentiated Thyroid Carcinoma
  45. Significance of the expression of major histocompatibility complex class II antigen, HLA-DR and -DQ, with recurrence of papillary thyroid cancer
  46. Pathogenetic Mechanisms and Therapeutic Implications of BRAFV600E in Papillary Thyroid Cancer
  47. The Relationship between the Expression of MHC Class II Antigens and the Clinical Prognosis of Papillary Thyroid Carcinoma Patients
  48. Two Cases of Simple Virilizing Congenital Adrenal Hyperplasia with Compound Heterozygous Mutations of CYP21 Gene
  49. An Orally Administered Multitarget Tyrosine Kinase Inhibitor, SU11248, Is a Novel Potent Inhibitor of Thyroid Oncogenic RET/Papillary Thyroid Cancer Kinases
  50. Influence of the BRAF V600E Mutation on Expression of Vascular Endothelial Growth Factor in Papillary Thyroid Cancer
  51. Regulation of Protein Kinase B Tyrosine Phosphorylation by Thyroid-Specific Oncogenic RET/PTC Kinases
  52. The Adequacy of Ultrasound-Guided Fine Needle Aspiration in Thyroid Nodules
  53. The Relationship between the BRAF Mutations in Thyroid Papillary Carcinomas and the Prognostic Factors
  54. Molecular Understanding of RET/PTC-Mediated Thyroid Carcinogenesis